WebMar 28, 2024 · The inclusion criteria were as follows: (1) pathological diagnosis of CRC confirmed by histological examination; (2) patients underwent radical surgical resection; (3) patients diagnosed as stage IV with resectable metastases and underwent intra-operative metastasis R0 resection; and (4) patients of all ages. WebJan 21, 2014 · Background Whether patients with resectable colorectal liver metastases (CRLM) receive survival benefit from neoadjuvant chemotherapy remains controversial. Methods We retrospectively analyzed 466 patients with resectable CRLM between 2000 and 2010. Patient characteristics and survival data were recorded. Results The patients were …
Clinicopathological features and prognosis in resectable
Webo As adjuvant treatment for unresectable metachronous metastases that converted to resectable disease after primary treatment. Biologic therapy is only appropriate for continuation of favorable response from conversion therapy; or Salivary Gland Tumors • As systemic therapy for HER2-positive recurrent disease with distant metastases in WebJul 1, 2024 · Adjuvant treatment for unresectable metachronous metastases that converted to resectable disease after primary treatment; or For synchronous liver only and/or lung only metastases that are unresectable or medically inoperable and remain unresectable with no progression of primary tumor after primary systemic therapy; or properties for sale in gourdon
Management of resectable metastatic colorectal cancer …
WebRe-evaluate for conversion to resectable every 2 mo. For resectable metachronous metastases, resection and/or local therapy is preferred, though neoadjuvant chemotherapy for 2-3 mo with FOLFOX, CAPOX, capecitabine, or 5-FU/leucovorin can be given: American Society of Clinical Oncology: WebOct 30, 2024 · Systemic Therapy for Advanced or Metastatic Disease 1. REGIMEN. DOSING. Capecitabine 2-4,a-d. ... (6 months perioperative treatment) for resectable, metachronous metastases. d ... WebThe incidence of both operated and non-operated metachronous contralateral inguinal hernia after 5 years was reported at 5.9%, after 15 years at 16.7%, and after 25 years at 29.0%. Metachronous contralateral inguinal hernia risk was increased with higher age, and decreased in primary right-sided surgery and higher BMI at index surgery. properties for sale in gosforth